Hippuristanol plus ABT-737 (an inhibitor of Bcl-2) synergistically increased cell death in Myc-driven lymphomas; likewise, the inhibition of eIF4AI is enough to improve the chemosensitivity of Myc-driven lymphomas to ABT-737 [118]. The gene discussed is EIF4A1; the disease is lymphoma.